Tag Archives: chemotherapy

Farletuzumab Trial Fails to Show Increase in PFS

A Phase III trial of a potential new treatment for ovarian cancer, farletuzumab, did not know any improvement in progression free survival. See a new article here

Posted in News | Also tagged , , | Leave a comment

EU Approves Avastin in Combination Therapy for Recurrent Ovarian Cancer

The European Commission approved the use of Avastin with Gemzar and Carboplatin for treatment of the first recurrence of ovarian cancer. See the article here

Posted in News | Also tagged , , , | Leave a comment

Researchers Uncover New Mechanism of Action for PARP Inhibitors

It appears that molecules currently classified as PARP inhibitors may work in one, or both, ways. One mechanism of action inhibits PARP enzyme activity; the other acts as a “PARP … Continue reading 

Posted in News | Also tagged , | Leave a comment

Dose Dense Therapy Appears Beneficial

A study of 637 Japanese women with ovarian, fallopian or primary peritoneal cancer showed that dose dense chemotherapy provided a benefit. The standard of care arm provided chemotherapy every three … Continue reading 

Posted in News | Also tagged , , , , | Leave a comment

Taxane Therapy Does Not Affect Pregnancy

A small retrospective study of women receiving taxane therapy for breast or ovarian cancer while pregnancy showed no statistically significant outcomes in maternal or fetal health. Read the abstract here

Posted in News | Also tagged , , , , | Leave a comment

When Less Is More – Editorial

The L.A. Times published an editorial July 29 summing up years of data showing that aggressively screening and treating people for cancer does not always benefit them. The editorial also … Continue reading 

Posted in News | Also tagged , , , , , , , , , , | Leave a comment

Fasting Before Chemotherapy?

There is a growing body of data indicating that fasting before chemotherapy renders cancer cells more sensitive to the toxic effects of those drugs. On the other side of the … Continue reading 

Posted in News | Also tagged , , , , , , , , | Leave a comment

Drug Costs an Issue in Cancer Care

The costs of drugs is increasingly becoming an issue in cancer care. The balance of quality and cost raises the issue of cost effectiveness. More presentations at the recent ASCO … Continue reading 

Posted in News | Also tagged , , , | Leave a comment

Study Shows Some Benefit to Second Debulking Surgery Followed by HIPEC

A study of 56 patients in Italy who had ovarian cancer showed that women with recurrent ovarian cancer benefited from a second debulking surgery followed by HIPEC. HIPEC, or hyperthermic … Continue reading 

Posted in News | Also tagged , , , , | Leave a comment

Phase III Trial of Bevacizumab with Chemotherapy

A Phase III trial of bevacizumab (Avastin) with gemcitabine + carboplatin versus gemcitabine + carboplatin in women with ovarian cancer showed the bevacizumab arm to improve progression free survival (PFS). … Continue reading 

Posted in News | Also tagged , , , , , | Leave a comment

Chemotherapy Causes Changes in the Brain

According to MRI results, chemotherapy causes small changes to fibers that connect neurons in the brain. These are associated with a decline in cognitive function. Read an article about the study … Continue reading 

Posted in News | Also tagged , , , , | Leave a comment

Race, Insurance Status, Influence Treatment of Ovarian Cancer

A study of more than 47,000 women with ovarian cancer found that uninsured and Medicaid patients were less likely to receive the standard of care. Additionally, women who were African … Continue reading 

Posted in News | Also tagged , , , , , , | Leave a comment